{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T14:54:43Z","timestamp":1783436083262,"version":"3.54.6"},"reference-count":17,"publisher":"Medknow","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["smedj"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.11622\/smedj.2018155","type":"journal-article","created":{"date-parts":[[2018,12,17]],"date-time":"2018-12-17T07:13:30Z","timestamp":1545030810000},"page":"303-308","source":"Crossref","is-referenced-by-count":15,"title":["Prevalence of growth and endocrine disorders in Malaysian children with transfusion-dependent thalassaemia"],"prefix":"10.4103","volume":"60","author":[{"given":"KA","family":"Tan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"SH","family":"Lum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Yahya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Krishnan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MY","family":"Jalaludin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"WS","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2581","published-online":{"date-parts":[[2019,6]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1056\/NEJM199409013310903","article-title":"Survival in medically treated patients with homozygous beta-thalassemia","volume":"331","author":"Olivieri","year":"1994","unstructured":"1. Olivieri NF, Nathan DG, MacMillan JH, et al. Survival in medically treated patients with homozygous beta-thalassemia. N Engl J Med 1994; 331:574-8.","journal-title":"N Engl J Med"},{"key":"ref1","doi-asserted-by":"publisher","first-page":"451","DOI":"10.4103\/2230-8210.183456","article-title":"Endocrine profile of \u03b2-thalassemia major patients followed from childhood to advanced adulthood in a tertiary care center","volume":"20","author":"De Sanctis","year":"2016","unstructured":"2. De Sanctis V, Elsedfy H, Soliman AT, et al. Endocrine profile of \u03b2-thalassemia major patients followed from childhood to advanced adulthood in a tertiary care center. Indian J Endocrinol Metab 2016; 20:451-9.","journal-title":"Indian J Endocrinol Metab"},{"key":"ref2","unstructured":"3. De Sanctis V, Eleftheriou A, Malaventura C; Thalassaemia International Federation Study Group on Growth and Endocrine Complications in Thalassaemia. Prevalence of endocrine complications and short stature in patients with thalassaemia major: a multicenter study by the Thalassaemia International Federation (TIF). Pediatr Endocrinol Rev 2004; 2 Suppl 2:249-55."},{"key":"ref3","unstructured":"4. Jameela S, Sabirah SO, Babam J, et al. Thalassaemia screening among students in a secondary school in Ampang, Malaysia. Med J Malaysia 2011; 66:522-4."},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"5. WHO Multicenter Growth Reference Study Group. WHO Child Growth Standards based on length\/height, weight and age. Acta Paediatr Suppl 2006; 450:76-85.","DOI":"10.1111\/j.1651-2227.2006.tb02378.x"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"8","DOI":"10.4103\/2230-8210.107808","article-title":"Growth and endocrine disorders in thalassemia: the international network on endocrine complications in thalassemia (I-CET) position statement and guidelines","volume":"17","author":"De Sanctis","year":"2013","unstructured":"6. De Sanctis V, Soliman AT, Elsedfy H, et al. Growth and endocrine disorders in thalassemia: the international network on endocrine complications in thalassemia (I-CET) position statement and guidelines. Indian J Endocrinol Metab 2013; 17:8-18.","journal-title":"Indian J Endocrinol Metab"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1373\/clinchem.2013.204222","article-title":"Marked biological variance in endocrine and biochemical markers in childhood: establishment of pediatric reference intervals using healthy community children from the CALIPER cohort","volume":"59","author":"Bailey","year":"2013","unstructured":"7. Bailey D, Colantonio D, Kyriakopoulou L, et al. Marked biological variance in endocrine and biochemical markers in childhood: establishment of pediatric reference intervals using healthy community children from the CALIPER cohort. Clin Chem 2013; 59:1393-405.","journal-title":"Clin Chem"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.4103\/2230-8210.122620","article-title":"Cortisol response to low dose versus standard dose (back-to-back) adrenocorticotrophic stimulation tests in children and young adults with thalassemia major","volume":"17","author":"Soliman","year":"2013","unstructured":"8. Soliman AT, Yassin M, Majuid NM, et al. Cortisol response to low dose versus standard dose (back-to-back) adrenocorticotrophic stimulation tests in children and young adults with thalassemia major. Indian J Endocrinol Metab 2013; 17:1046-52.","journal-title":"Indian J Endocrinol Metab"},{"key":"ref8","doi-asserted-by":"publisher","unstructured":"9. Hanas R, Donaghue KC, Klingensmith G, Swift PG. ISPAD clinical practice consensus guidelines 2009 compendium. Introduction. Pediatr Diabetes 2009; 10 Suppl 12:1-12.","DOI":"10.1111\/j.1399-5448.2009.00577.x"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1542\/peds.2007-1894","article-title":"Vitamin D deficiency in children and its management: review of current knowledge and recommendations","volume":"122","author":"Misra","year":"2008","unstructured":"10. Misra M, Pacaud D, Petryk A, Collett-Solberg PF, Kappy M; Drug and Therapeutics Committee of the Lawson Wilkins Pediatric Endocrine Society. Vitamin D deficiency in children and its management: review of current knowledge and recommendations. Pediatrics 2008; 122:398-417.","journal-title":"Pediatrics"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1097\/00000441-195909000-00030","article-title":"Radiographic atlas of skeletal development of the hand and wrist","volume":"238","author":"WW","year":"1959","unstructured":"11. Greulich WW, Pyle SI. Radiographic atlas of skeletal development of the hand and wrist. Am J Med Sci 1959; 238:393.","journal-title":"Am J Med Sci"},{"key":"ref11","unstructured":"12. Borgna-Pignatti C, Rugolotto S, De Stefano P, et al. Survival and complications in patients with thalassemia major treated with transfusion and deferoxamine. Haematologica 2004; 89:1187-93."},{"key":"ref12","unstructured":"13. Cappellini MD, Cohen A, Porter J, Taher A, Viprakasit V, eds. Guidelines for the Management of Transfusion Dependent Thalassaemia (TDT) [Internet]. 3rd ed. Nicosia, CY: Thalassaemia International Federation, 2014."},{"key":"ref13","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1111\/j.1365-2141.2009.07793.x","article-title":"Differences in the prevalence of growth, endocrine and vitamin D abnormalities among the various thalassaemia syndromes in North America","volume":"146","author":"MG","year":"2009","unstructured":"14. Vogiatzi MG, Macklin EA, Trachtenberg FL, et al; Thalassemia Clinical Research Network. Differences in the prevalence of growth, endocrine and vitamin D abnormalities among the various thalassaemia syndromes in North America. Br J Haematol 2009; 146:546-56.","journal-title":"Br J Haematol"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1179\/2046905514Y.0000000160","article-title":"Endocrinopathies in adolescents with thalassaemia major receiving oral iron chelation therapy","volume":"36","author":"Sharma","year":"2016","unstructured":"15. Sharma R, Seth A, Chandra J, et al. Endocrinopathies in adolescents with thalassaemia major receiving oral iron chelation therapy. Paediatr Int Child Health 2016; 36:22-7.","journal-title":"Paediatr Int Child Health"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"361","DOI":"10.5144\/0256-4947.2008.361","article-title":"A cross-sectional study of metabolic and endocrine complications in beta-thalassemia major","volume":"28","author":"Najafipour","year":"2008","unstructured":"16. Najafipour F, Aliasgarzadeh A, Aghamohamadzadeh N, et al. A cross-sectional study of metabolic and endocrine complications in beta-thalassemia major. Ann Saudi Med 2008; 28:361-6.","journal-title":"Ann Saudi Med"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"607","DOI":"10.3109\/08880018.2014.898724","article-title":"Endocrinopathies in Turkish children with beta thalassemia major: results from a single center study","volume":"31","author":"Isik","year":"2014","unstructured":"17. Isik P, Yarali N, Tavil B, et al. Endocrinopathies in Turkish children with beta thalassemia major: results from a single center study. Pediatr Hematol Oncol 2014; 31:607-15.","journal-title":"Pediatr Hematol Oncol"}],"container-title":["Singapore Medical Journal"],"original-title":[],"link":[{"URL":"http:\/\/www.smj.org.sg\/article\/prevalence-growth-and-endocrine-disorders-malaysian-children-transfusion-dependent","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,9]],"date-time":"2022-08-09T10:49:34Z","timestamp":1660042174000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.smj.org.sg\/article\/prevalence-growth-and-endocrine-disorders-malaysian-children-transfusion-dependent"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":17,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2019,6]]},"published-print":{"date-parts":[[2019,6]]}},"URL":"https:\/\/doi.org\/10.11622\/smedj.2018155","relation":{},"ISSN":["0037-5675"],"issn-type":[{"value":"0037-5675","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6]]}}}